| Dr Laura Hampel, MD | |
|
10475 Reading Rd, Cincinnati, OH 45241-2563 | |
| (513) 563-2202 | |
| (513) 751-2327 |
| Full Name | Dr Laura Hampel |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 8 Years |
| Location | 10475 Reading Rd, Cincinnati, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013366426 | NPI | - | NPPES |
| 2565399 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 57.028256 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Good Samaritan Hospital | Cincinnati, OH | Hospital |
| Bethesda North | Cincinnati, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Trihealth H Llc | 1850570458 | 668 |
News Archive
Æterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its partner Keryx Biopharmaceuticals Inc. reported updated efficacy and safety data as well as new survival data on the clinical activity of perifosine (KRX-0401) in combination with bortezomib (Velcade(R)) (+/- dexamethasone) in patients with relapsed/refractory multiple myeloma.
Eating disorder charities in Britain are criticising the decision by the British Fashion Council to abandon plans to insist models undergo a health test before taking to the catwalk.
Children's Hospital & Research Center Oakland announced today that the US Food and Drug Administration (FDA) has granted clearance of an Investigational New Drug (IND) application to introduce Trappsol Cyclo (Hydroxypropyl Beta Cyclodextrin or HPβCD) into the brains of six year old identical twin girls dying of a rare brain-destroying cholesterol disease called Niemann Pick Type C (NPC).
A research team in the Netherlands has found that cells from burn eschar, the non-viable tissue remaining after burn injury and normally removed to prevent infection, can be a source of mesenchymal cells that may be used for tissue engineering.
› Verified 4 days ago
| Entity Name | Trihealth G Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295862944 PECOS PAC ID: 0749222651 Enrollment ID: O20050601000358 |
News Archive
Æterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its partner Keryx Biopharmaceuticals Inc. reported updated efficacy and safety data as well as new survival data on the clinical activity of perifosine (KRX-0401) in combination with bortezomib (Velcade(R)) (+/- dexamethasone) in patients with relapsed/refractory multiple myeloma.
Eating disorder charities in Britain are criticising the decision by the British Fashion Council to abandon plans to insist models undergo a health test before taking to the catwalk.
Children's Hospital & Research Center Oakland announced today that the US Food and Drug Administration (FDA) has granted clearance of an Investigational New Drug (IND) application to introduce Trappsol Cyclo (Hydroxypropyl Beta Cyclodextrin or HPβCD) into the brains of six year old identical twin girls dying of a rare brain-destroying cholesterol disease called Niemann Pick Type C (NPC).
A research team in the Netherlands has found that cells from burn eschar, the non-viable tissue remaining after burn injury and normally removed to prevent infection, can be a source of mesenchymal cells that may be used for tissue engineering.
› Verified 4 days ago
| Entity Name | Trihealth H Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811215742 PECOS PAC ID: 1850570458 Enrollment ID: O20110128000356 |
News Archive
Æterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its partner Keryx Biopharmaceuticals Inc. reported updated efficacy and safety data as well as new survival data on the clinical activity of perifosine (KRX-0401) in combination with bortezomib (Velcade(R)) (+/- dexamethasone) in patients with relapsed/refractory multiple myeloma.
Eating disorder charities in Britain are criticising the decision by the British Fashion Council to abandon plans to insist models undergo a health test before taking to the catwalk.
Children's Hospital & Research Center Oakland announced today that the US Food and Drug Administration (FDA) has granted clearance of an Investigational New Drug (IND) application to introduce Trappsol Cyclo (Hydroxypropyl Beta Cyclodextrin or HPβCD) into the brains of six year old identical twin girls dying of a rare brain-destroying cholesterol disease called Niemann Pick Type C (NPC).
A research team in the Netherlands has found that cells from burn eschar, the non-viable tissue remaining after burn injury and normally removed to prevent infection, can be a source of mesenchymal cells that may be used for tissue engineering.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Laura Hampel, MD 375 Dixmyth Ave, Cincinnati, OH 45220-2475 Ph: () - | Dr Laura Hampel, MD 10475 Reading Rd, Cincinnati, OH 45241-2563 Ph: (513) 563-2202 |
News Archive
Æterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its partner Keryx Biopharmaceuticals Inc. reported updated efficacy and safety data as well as new survival data on the clinical activity of perifosine (KRX-0401) in combination with bortezomib (Velcade(R)) (+/- dexamethasone) in patients with relapsed/refractory multiple myeloma.
Eating disorder charities in Britain are criticising the decision by the British Fashion Council to abandon plans to insist models undergo a health test before taking to the catwalk.
Children's Hospital & Research Center Oakland announced today that the US Food and Drug Administration (FDA) has granted clearance of an Investigational New Drug (IND) application to introduce Trappsol Cyclo (Hydroxypropyl Beta Cyclodextrin or HPβCD) into the brains of six year old identical twin girls dying of a rare brain-destroying cholesterol disease called Niemann Pick Type C (NPC).
A research team in the Netherlands has found that cells from burn eschar, the non-viable tissue remaining after burn injury and normally removed to prevent infection, can be a source of mesenchymal cells that may be used for tissue engineering.
› Verified 4 days ago
Ellen W Feld, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 8231 Cornell Rd, Suite 320, Cincinnati, OH 45249 Phone: 513-794-1500 Fax: 513-794-1500 | |
Renee Louise Klee, CNM Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7495 State Rd, Suite 300, Cincinnati, OH 45255 Phone: 513-231-3447 Fax: 513-231-3761 | |
Helmut F Schellhas, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3219 Clifton Ave, Suite 100, Cincinnati, OH 45220 Phone: 513-862-1888 Fax: 513-862-3616 | |
Dr. Sarah E Bartlett, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 8350 E Kemper Rd Ste A, Cincinnati, OH 45249 Phone: 513-404-4166 | |
Anuja Gupta, M.D Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 8000 5 Mile Rd Ste 207, Cincinnati, OH 45230 Phone: 513-474-2870 Fax: 513-688-8585 | |
Dr. Ajit Gubbi, D.O Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 601 Ivy Gtwy Ste 1100, Cincinnati, OH 45245 Phone: 513-751-2273 Fax: 513-751-1840 |